• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

莪术醇:从植物根源到癌症根源。

Curcumol: From Plant Roots to Cancer Roots.

机构信息

Dental Hospital, Jilin University, Changchun 130021, China.

The Key Laboratory of Molecular Epigenetics of MOE, Institute of Genetics and Cytology, Northeast Normal University, Changchun 130024, China.

出版信息

Int J Biol Sci. 2019 Jun 4;15(8):1600-1609. doi: 10.7150/ijbs.34716. eCollection 2019.

DOI:10.7150/ijbs.34716
PMID:31360103
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6643219/
Abstract

Natural products, an infinite treasure of bioactive scaffolds, have provided an excellent reservoir for the discovery of drugs since millennium. These naturally occurring, biologically active and therapeutically effective chemical entities have emerged as novel paradigm for the prevention of various diseases. This review aims to give an update on the sources as well as pharmacological profile of curcumol, a pharmacologically active sesquiterpenoid, which is an imperative bioactive constituent of several plants mainly from genus . Curcumol has potential to fight against cancer, oxidative stress, neurodegeneration, microbial infections, and inflammation. Curcumol has been documented as potent inducer of apoptosis in numerous cancer cells via targeting key signaling pathways as MAPK/ERK, PI3K/Akt and NF-κB which are generally deregulated in several cancers. The reported data reveals multitarget activity of curcumol in cancer treatment suggesting its importance as anticancer drug in future. It is speculated that curcumol may provide an excellent opportunity for the cure of cancer but further investigations on mechanism of its action and preclinical trials are still mandatory to further validate the potential of this natural cancer killer in anticancer therapies.

摘要

天然产物是生物活性支架的无尽宝藏,千百年来为药物发现提供了极好的来源。这些天然存在的、具有生物活性和治疗效果的化学物质已经成为预防各种疾病的新范例。本综述旨在介绍姜黄素的来源和药理学概况,姜黄素是一种具有药理活性的倍半萜烯,是几种植物的重要生物活性成分,主要来自 属。姜黄素具有对抗癌症、氧化应激、神经退行性疾病、微生物感染和炎症的潜力。姜黄素已被证明通过靶向 MAPK/ERK、PI3K/Akt 和 NF-κB 等关键信号通路,在许多癌细胞中作为有效的凋亡诱导剂,这些信号通路在多种癌症中通常失调。报道的数据显示,姜黄素在癌症治疗中具有多靶点活性,表明它作为抗癌药物在未来的重要性。有人推测,姜黄素可能为癌症治疗提供了一个极好的机会,但仍需要进一步的机制研究和临床前试验来进一步验证这种天然抗癌杀手在癌症治疗中的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e937/6643219/dce0817f07ce/ijbsv15p1600g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e937/6643219/b33c70b7d9c6/ijbsv15p1600g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e937/6643219/5645d93b8d99/ijbsv15p1600g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e937/6643219/3a9e6962715d/ijbsv15p1600g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e937/6643219/dce0817f07ce/ijbsv15p1600g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e937/6643219/b33c70b7d9c6/ijbsv15p1600g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e937/6643219/5645d93b8d99/ijbsv15p1600g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e937/6643219/3a9e6962715d/ijbsv15p1600g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e937/6643219/dce0817f07ce/ijbsv15p1600g004.jpg

相似文献

1
Curcumol: From Plant Roots to Cancer Roots.莪术醇:从植物根源到癌症根源。
Int J Biol Sci. 2019 Jun 4;15(8):1600-1609. doi: 10.7150/ijbs.34716. eCollection 2019.
2
Curcumol Suppresses Breast Cancer Cell Metastasis by Inhibiting MMP-9 Via JNK1/2 and Akt-Dependent NF-κB Signaling Pathways.莪术醇通过JNK1/2和Akt依赖的NF-κB信号通路抑制MMP-9,从而抑制乳腺癌细胞转移。
Integr Cancer Ther. 2016 Jun;15(2):216-25. doi: 10.1177/1534735416642865. Epub 2016 Apr 28.
3
Curcumol induces cell cycle arrest in colon cancer cells via reactive oxygen species and Akt/ GSK3β/cyclin D1 pathway.姜黄素通过活性氧和 Akt/GSK3β/细胞周期蛋白 D1 通路诱导结肠癌细胞周期停滞。
J Ethnopharmacol. 2018 Jan 10;210:1-9. doi: 10.1016/j.jep.2017.06.037. Epub 2017 Jul 4.
4
Curcumol inhibits colorectal cancer proliferation by targeting miR-21 and modulated PTEN/PI3K/Akt pathways.姜黄素通过靶向 miR-21 并调节 PTEN/PI3K/Akt 通路抑制结直肠癌细胞增殖。
Life Sci. 2019 Mar 15;221:354-361. doi: 10.1016/j.lfs.2019.02.049. Epub 2019 Feb 24.
5
Curcumol induces cell cycle arrest and apoptosis by inhibiting IGF-1R/PI3K/Akt signaling pathway in human nasopharyngeal carcinoma CNE-2 cells.姜黄素通过抑制 IGF-1R/PI3K/Akt 信号通路诱导人鼻咽癌细胞 CNE-2 的细胞周期停滞和凋亡。
Phytother Res. 2018 Nov;32(11):2214-2225. doi: 10.1002/ptr.6158. Epub 2018 Aug 2.
6
Curcumol alleviates cardiac remodeling via the AKT/NF-κB pathway.姜黄素通过 AKT/NF-κB 通路减轻心脏重构。
Int Immunopharmacol. 2023 Sep;122:110527. doi: 10.1016/j.intimp.2023.110527. Epub 2023 Jun 29.
7
Curcumol induces HSC-T6 cell death through suppression of Bcl-2: involvement of PI3K and NF-κB pathways.莪术醇通过抑制Bcl-2诱导肝星状细胞T6细胞死亡:PI3K和NF-κB信号通路的参与
Eur J Pharm Sci. 2014 Dec 18;65:21-8. doi: 10.1016/j.ejps.2014.09.001. Epub 2014 Sep 9.
8
Identification and validation nucleolin as a target of curcumol in nasopharyngeal carcinoma cells.鉴定和验证核仁素为姜黄素在鼻咽癌细胞中的靶标。
J Proteomics. 2018 Jun 30;182:1-11. doi: 10.1016/j.jprot.2018.04.025. Epub 2018 Apr 22.
9
Therapeutic Effects of Curcumol in Several Diseases; An Overview.莪术醇在几种疾病中的治疗效果综述。
Nutr Cancer. 2021;73(2):181-195. doi: 10.1080/01635581.2020.1749676. Epub 2020 Apr 14.
10
Curcumol Inhibits Growth and Induces Apoptosis of Colorectal Cancer LoVo Cell Line via IGF-1R and p38 MAPK Pathway.莪术醇通过IGF-1R和p38 MAPK途径抑制结直肠癌LoVo细胞系的生长并诱导其凋亡。
Int J Mol Sci. 2015 Aug 20;16(8):19851-67. doi: 10.3390/ijms160819851.

引用本文的文献

1
Emerging Roles of GDF15 in Metabolic and Cardiovascular Diseases.生长分化因子15在代谢性疾病和心血管疾病中的新作用
Research (Wash D C). 2025 Aug 19;8:0832. doi: 10.34133/research.0832. eCollection 2025.
2
: An anti-cancer traditional Chinese medicine.一种抗癌中药。
Chin Herb Med. 2025 Apr 24;17(3):428-447. doi: 10.1016/j.chmed.2025.04.006. eCollection 2025 Jul.
3
Multi-omics analysis of the anti-cancer effects of curcumol in endometrial carcinoma.莪术醇对子宫内膜癌抗癌作用的多组学分析

本文引用的文献

1
Curcumol inhibits colorectal cancer proliferation by targeting miR-21 and modulated PTEN/PI3K/Akt pathways.姜黄素通过靶向 miR-21 并调节 PTEN/PI3K/Akt 通路抑制结直肠癌细胞增殖。
Life Sci. 2019 Mar 15;221:354-361. doi: 10.1016/j.lfs.2019.02.049. Epub 2019 Feb 24.
2
Curcumol induces cell cycle arrest and apoptosis by inhibiting IGF-1R/PI3K/Akt signaling pathway in human nasopharyngeal carcinoma CNE-2 cells.姜黄素通过抑制 IGF-1R/PI3K/Akt 信号通路诱导人鼻咽癌细胞 CNE-2 的细胞周期停滞和凋亡。
Phytother Res. 2018 Nov;32(11):2214-2225. doi: 10.1002/ptr.6158. Epub 2018 Aug 2.
3
Astragalin: A Bioactive Phytochemical with Potential Therapeutic Activities.
Front Pharmacol. 2025 Jul 3;16:1565959. doi: 10.3389/fphar.2025.1565959. eCollection 2025.
4
Oleuropein regulates ubiquitination-mediated Mcl-1 turnover and exhibits antitumor activity.橄榄苦苷调节泛素化介导的Mcl-1周转并具有抗肿瘤活性。
Cancer Gene Ther. 2025 Jun 12. doi: 10.1038/s41417-025-00921-9.
5
Mechanism of Curcumol Targeting the OTUB1/TGFBI Ubiquitination Pathway in the Inhibition of Angiogenesis in Colon Cancer.莪术醇靶向OTUB1/TGFBI泛素化途径抑制结肠癌血管生成的机制
Int J Mol Sci. 2025 May 21;26(10):4899. doi: 10.3390/ijms26104899.
6
Transnasal PLGA Nanoparticles with Terpene Permeation Enhancers: Membrane Remodeling and Tight Junction Modulation for Enhanced Brain Drug Delivery.含有萜烯渗透促进剂的经鼻PLGA纳米颗粒:用于增强脑药物递送的膜重塑和紧密连接调节
Int J Mol Sci. 2025 Apr 18;26(8):3861. doi: 10.3390/ijms26083861.
7
Reversal of sorafenib resistance in hepatocellular carcinoma by curcumol: insights from network pharmacology, molecular docking, and experimental validation.莪术醇逆转肝癌中索拉非尼耐药性:来自网络药理学、分子对接和实验验证的见解
Front Pharmacol. 2025 Apr 2;16:1514997. doi: 10.3389/fphar.2025.1514997. eCollection 2025.
8
Piperlongumine overcomes osimertinib resistance via governing ubiquitination-modulated Sp1 turnover.胡椒碱通过调控泛素化介导的Sp1周转克服奥希替尼耐药性。
JCI Insight. 2025 Mar 24;10(6):e186165. doi: 10.1172/jci.insight.186165.
9
Curcumol attenuates hyperproliferation and inflammatory response in a psoriatic HaCaT keratinocyte model by inhibiting the PI3K-Akt pathway and ameliorates skin lesions and inflammatory status in psoriasis-like mice.莪术醇通过抑制PI3K-Akt信号通路减轻银屑病HaCaT角质形成细胞模型中的过度增殖和炎症反应,并改善银屑病样小鼠的皮肤损伤和炎症状态。
Inflammopharmacology. 2025 Apr;33(4):2165-2178. doi: 10.1007/s10787-025-01708-y. Epub 2025 Mar 10.
10
Curzerenone inactivates the nuclear factor-kappa B signaling to suppress malignancy and immune evasion in cervical cancer by targeting CSNK2B.柯里泽烯酮通过靶向酪蛋白激酶2β亚基使核因子-κB信号失活,从而抑制宫颈癌的恶性肿瘤生长和免疫逃逸。
Hum Cell. 2024 Dec 24;38(1):35. doi: 10.1007/s13577-024-01164-w.
紫云英苷:一种具有潜在治疗活性的生物活性植物化学物质。
Adv Pharmacol Sci. 2018 May 2;2018:9794625. doi: 10.1155/2018/9794625. eCollection 2018.
4
Anti-proliferative benefit of curcumol on human bladder cancer cells via inactivating EZH2 effector.姜黄素通过抑制 EZH2 效应物对人膀胱癌细胞的抗增殖作用。
Biomed Pharmacother. 2018 Aug;104:798-805. doi: 10.1016/j.biopha.2018.05.101. Epub 2018 May 29.
5
Identification and validation nucleolin as a target of curcumol in nasopharyngeal carcinoma cells.鉴定和验证核仁素为姜黄素在鼻咽癌细胞中的靶标。
J Proteomics. 2018 Jun 30;182:1-11. doi: 10.1016/j.jprot.2018.04.025. Epub 2018 Apr 22.
6
Curcumol attenuates epithelial-mesenchymal transition of nasopharyngeal carcinoma cells via TGF-β1.姜黄素通过 TGF-β1 减轻鼻咽癌细胞的上皮间质转化。
Mol Med Rep. 2018 Jun;17(6):7513-7520. doi: 10.3892/mmr.2018.8817. Epub 2018 Mar 28.
7
Role of Plant-Derived Flavonoids and Their Mechanism in Attenuation of Alzheimer's and Parkinson's Diseases: An Update of Recent Data.植物源性类黄酮及其在减轻阿尔茨海默病和帕金森病中的作用:最新数据的更新。
Molecules. 2018 Apr 2;23(4):814. doi: 10.3390/molecules23040814.
8
Role of Plant Derived Alkaloids and Their Mechanism in Neurodegenerative Disorders.植物源性生物碱在神经退行性疾病中的作用及其机制。
Int J Biol Sci. 2018 Mar 9;14(3):341-357. doi: 10.7150/ijbs.23247. eCollection 2018.
9
Antifungal activity, main active components and mechanism of Curcuma longa extract against Fusarium graminearum.姜黄提取物对禾谷镰刀菌的抑菌活性、主要活性成分及作用机制。
PLoS One. 2018 Mar 15;13(3):e0194284. doi: 10.1371/journal.pone.0194284. eCollection 2018.
10
Curcumol potentiates celecoxib-induced growth inhibition and apoptosis in human non-small cell lung cancer.莪术醇增强塞来昔布对人非小细胞肺癌的生长抑制作用及诱导凋亡作用。
Oncotarget. 2017 Dec 14;8(70):115526-115545. doi: 10.18632/oncotarget.23308. eCollection 2017 Dec 29.